These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15090249)

  • 1. A simple kinetic method for rapid mechanistic analysis of reversible enzyme inhibitors.
    Lai CJ; Wu JC
    Assay Drug Dev Technol; 2003 Aug; 1(4):527-35. PubMed ID: 15090249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction between full and partial inhibitors acting on a single enzyme. A theoretical analysis.
    Palatini P
    Mol Pharmacol; 1983 Jul; 24(1):30-41. PubMed ID: 6865924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
    Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
    J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereospecificity, substrate, and inhibitory properties of nucleoside diphosphate analogs for creatine and pyruvate kinases.
    Wennefors CK; Dobrikov MI; Xu Z; Li P; Shaw BR
    Bioorg Chem; 2008 Aug; 36(4):169-77. PubMed ID: 18433830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic differences in inhibition of ubiquinol cytochrome c reductase by the proximal Qo-site inhibitors famoxadone and methoxyacrylate stilbene.
    Pember SO; Fleck LC; Moberg WK; Walker MP
    Arch Biochem Biophys; 2005 Mar; 435(2):280-90. PubMed ID: 15708371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new plot for the kinetic analysis of dead-end enzyme inhibitors.
    Roveri OA
    Biochem Int; 1985 Jul; 11(1):11-9. PubMed ID: 4038316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining balanced conditions for inhibitor screening assays that target bisubstrate enzymes.
    Yang J; Copeland RA; Lai Z
    J Biomol Screen; 2009 Feb; 14(2):111-20. PubMed ID: 19196704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A graphical method for determining the number of essential sites in enzymes with multiple binding sites for a ligand.
    Wang ZX; Srivastava DK
    Anal Biochem; 1994 Jan; 216(1):15-26. PubMed ID: 8135345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein ligand interactions. Indole alkaloids as inhibitors for lactate dehydrogenase.
    Wade TG; Whiteley CG
    Biochem Int; 1987 Feb; 14(2):189-97. PubMed ID: 2883975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overall kinetic mechanism of saccharopine dehydrogenase from Saccharomyces cerevisiae.
    Xu H; West AH; Cook PF
    Biochemistry; 2006 Oct; 45(39):12156-66. PubMed ID: 17002315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galloflavin (CAS 568-80-9): a novel inhibitor of lactate dehydrogenase.
    Manerba M; Vettraino M; Fiume L; Di Stefano G; Sartini A; Giacomini E; Buonfiglio R; Roberti M; Recanatini M
    ChemMedChem; 2012 Feb; 7(2):311-7. PubMed ID: 22052811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double inhibition of D-glyceraldehyde-3-phosphate dehydrogenase and lactate dehydrogenase.
    Lien LV; Ecsedi G; Keleti T
    Acta Biochim Biophys Acad Sci Hung; 1979; 14(1-2):11-7. PubMed ID: 517106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mechanistic kinetic description of lactate dehydrogenase elucidating cancer diagnosis and inhibitor evaluation.
    Tang P; Xu J; Oliveira CL; Li ZJ; Liu S
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):564-571. PubMed ID: 28114833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A graphical method for determining inhibition constants.
    Yoshino M; Murakami K
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1288-90. PubMed ID: 19912063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase.
    Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP
    Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native states of adenylate kinase are two active sub-ensembles.
    Han Y; Li X; Pan X
    FEBS Lett; 2002 Sep; 528(1-3):161-5. PubMed ID: 12297297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the binding site for gossypol-like inhibitors of Plasmodium falciparum lactate dehydrogenase.
    Conners R; Schambach F; Read J; Cameron A; Sessions RB; Vivas L; Easton A; Croft SL; Brady RL
    Mol Biochem Parasitol; 2005 Aug; 142(2):137-48. PubMed ID: 15978953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel method for evaluation and screening of caspase inhibitory peptides by the amino acid positional fitness score.
    Yoshimori A; Takasawa R; Tanuma S
    BMC Pharmacol; 2004 May; 4():7. PubMed ID: 15154972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and characterization of a substrate selective p38alpha inhibitor.
    Davidson W; Frego L; Peet GW; Kroe RR; Labadia ME; Lukas SM; Snow RJ; Jakes S; Grygon CA; Pargellis C; Werneburg BG
    Biochemistry; 2004 Sep; 43(37):11658-71. PubMed ID: 15362850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme inhibitor screening by capillary electrophoresis with an on-column immobilized enzyme microreactor created by an ionic binding technique.
    Tang ZM; Kang JW
    Anal Chem; 2006 Apr; 78(8):2514-20. PubMed ID: 16615758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.